BridgeMD
New treatment option for Cartilage Lesion
Official title A Talus Implant in Patients Between 20-60 Years of Age Followed up for a Minimum of 2 Years After Surgery
ClinicalTrials.gov ID: NCT06932380
What this study is testing
- What it's testing
- The project will investigate safety, feasibility and efficiency when using Episurf Episeal talus implant in patients with osteochondral ankle injuries. Assessments includes revision rate, complications, pain, function and quality of life over two years.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 60
You may be able to join if
- Patients aged 20-60 years with symptomatic osteochondral lesions of the ankle where conservative treatment or previous surgery has been...
- Patients with a limited cartilage defect that qualifies for Episealer implantation.
- Patients who have provided written informed consent to participate in the study.
You likely can't join if
- Patients with an active infection in the ankle.
- Patients with extensive cartilage damage where Episealer is not indicated.
- Patients with osteoarthritic changes on the tibial side of the ankle joint.
- Patients with severe joint instability.
- Patients with severe neurological or systemic diseases.
- Patients who smoke.
See the full eligibility criteria
- Patients aged 20-60 years with symptomatic osteochondral lesions of the ankle where conservative treatment or previous surgery has been unsatisfactory.
- Patients with a limited cartilage defect that qualifies for Episealer implantation.
- Patients who have provided written informed consent to participate in the study.
- Patients with an active infection in the ankle.
- Patients with extensive cartilage damage where Episealer is not indicated.
- Patients with osteoarthritic changes on the tibial side of the ankle joint.
- Patients with severe joint instability.
- Patients with severe neurological or systemic diseases.
- Patients who smoke.
- Patients with substance abuse issues.
- Patients unable to attend follow-ups due to distance or other factors.
The study team makes the final eligibility decision.
Where it's taking place
- Drammen, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Drammen, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.